Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell LinesMaria Pinkerneil, Günter Niegisch|Targeted Oncology|2016Cited by 57
HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal TransitionAnanda Ayyappan Jaguva Vasudevan, Günter Niegisch|International Journal of Molecular Sciences|2019Cited by 19
Evaluation of <scp>HER2</scp> expression in urothelial carcinoma cells as a biomarker for circulating tumor cellsAlessandro Nini, Günter Niegisch|Cytometry Part B Clinical Cytometry|2020Cited by 16
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatmentMaria Lehmann, Günter Niegisch|Journal of Experimental & Clinical Cancer Research|2014Cited by 1